Tilray has agreed with Worldpharma Biotech to export GMP certified medical cannabis from Portugal to Spain, according to the company’s press release. The shipment is the first medical cannabis import into Spain by Worldpharma and the 17th country to receive Tilray medical cannabis worldwide.
- Spain’s food and drug administration has already approved Worldpharma to import Tilray’s GMP-certified medical cannabis as raw material from its Portugal facility.
- With Tilray’s pharmaceutical-grade cannabis, Worldpharma will develop medical cannabis products for clinical trials in Spanish hospitals for diseases such as Alzheimer’s, Parkinson’s disease, and skin inflammation.
- Tilray has a track record as a company committed to making GMP-certified, pharmaceutical-grade medical cannabis products for patients in need worldwide.
Tilray and Worldpharma stocks are currently declining. TLRY is down 0.15% in premarket, OWPC is down 8.58%